Brief

Boehringer Appeals HHS Win In Medicare Drug Price Suit

By Hannah Albarazi · July 29, 2024, 5:25 PM EDT

Boehringer Ingelheim Pharmaceuticals Inc. notified a Connecticut federal court Friday that it will appeal its loss in a lawsuit challenging a new Medicare drug price negotiation program on the grounds that...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Notice of appeal

Case Information

Case Title

Boehringer Ingelheim Pharmaceuticals, Inc. v. United States Department of Health and Human Services et al

Case Number

3:23-cv-01103

Court

Connecticut

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

August 18, 2023

Recent Articles By Hannah

October 29, 2024
Retired Fed. Circ. Judge Backs Invisalign In Monopoly Cases
October 11, 2024
Apple Watch Patents Dodge Ax As Masimo Jury Trial Nears
October 01, 2024
From AI To Enviro: The Top Biz Bills Calif. Gov. Inked Into Law
September 27, 2024
Why Many Drugs Remain Pricey 40 Years After Hatch-Waxman
September 11, 2024
Top Calif. Biz Bills Sitting On Gov. Newsom's Desk
September 03, 2024
3rd Circ.: Biotech Must Pay Royalties Despite Expired Patents
August 20, 2024
Ala. AG Can't Prosecute Aiding Abortion Travel, DOJ Says
August 13, 2024
Are 'Public Advantage' Laws Driving Up Healthcare Costs?
July 30, 2024
5th Circ. Ruling Places FCC Rural Telehealth Funding In Peril
July 09, 2024
With Chevron's End, LGBTQ+ Healthcare Regs Face New Risk